226 related articles for article (PubMed ID: 26784016)
1. Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach.
Panicker GK; Karnad DR; Kadam P; Badilini F; Damle A; Kothari S
Br J Pharmacol; 2016 Apr; 173(8):1373-80. PubMed ID: 26784016
[TBL] [Abstract][Full Text] [Related]
2. A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers.
Hossain M; Zhou M; Tiffany C; Dumont E; Darpo B
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223381
[TBL] [Abstract][Full Text] [Related]
3. Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.
Taubel J; Ferber G; Lorch U; Batchvarov V; Savelieva I; Camm AJ
Br J Clin Pharmacol; 2014 Jan; 77(1):170-9. PubMed ID: 23713767
[TBL] [Abstract][Full Text] [Related]
4. Effects of moxifloxacin on the proarrhythmic surrogate markers in healthy Filipino subjects: Exposure-response modeling using ECG data of thorough QT/QTc study.
Matsukura S; Nakamura Y; Hoshiai K; Hayashi T; Koga T; Goto A; Chiba K; Lubna NJ; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Ando K; Naito AT; Sugiyama A
J Pharmacol Sci; 2018 Apr; 136(4):234-241. PubMed ID: 29627227
[TBL] [Abstract][Full Text] [Related]
5. Randomized study of the effect of gadopiclenol, a new gadolinium-based contrast agent, on the QTc interval in healthy subjects.
Funck-Brentano C; Felices M; Le Fur N; Dubourdieu C; Desché P; Vanhoutte F; Voiriot P
Br J Clin Pharmacol; 2020 Nov; 86(11):2174-2181. PubMed ID: 32302009
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced QT prolongation when QT interval is measured in each of the 12 ECG leads in men and women in a thorough QT study.
Panicker GK; Salvi V; Karnad DR; Chakraborty S; Manohar D; Lokhandwala Y; Kothari S
J Electrocardiol; 2014; 47(2):155-7. PubMed ID: 24388488
[TBL] [Abstract][Full Text] [Related]
7. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.
Morganroth J; Wang Y; Thorn M; Kumagai Y; Harris S; Stockbridge N; Kleiman R; Shah R
Br J Clin Pharmacol; 2015 Sep; 80(3):446-59. PubMed ID: 26011050
[TBL] [Abstract][Full Text] [Related]
9. Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study.
Shah RR; Maison-Blanche P; Duvauchelle T; Robert P; Denis E
Eur J Clin Pharmacol; 2015 Dec; 71(12):1451-9. PubMed ID: 26423621
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
[TBL] [Abstract][Full Text] [Related]
11. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
[TBL] [Abstract][Full Text] [Related]
12. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
[TBL] [Abstract][Full Text] [Related]
13. Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects.
Täubel J; Ferber G; Fox G; Fernandes S; Lorch U; Camm AJ
Br J Clin Pharmacol; 2017 Feb; 83(2):339-348. PubMed ID: 27618796
[TBL] [Abstract][Full Text] [Related]
14. No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects.
Mu S; Darpo B; Tang Z; Novotny W; Tawashi M; Xue H; Willett M; Lin L; Sahasranaman S; Ou YC
Clin Transl Sci; 2020 Sep; 13(5):923-931. PubMed ID: 32144955
[TBL] [Abstract][Full Text] [Related]
15. Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men.
Olsson H; Petri N; Erichsen L; Malmberg A; Grundemar L
Clin Drug Investig; 2017 Sep; 37(9):873-879. PubMed ID: 28660498
[TBL] [Abstract][Full Text] [Related]
16. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
Stier B; Fossler M; Liu F; Caltabiano S
Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study.
Komatsu R; Honda M; Holzgrefe HH; Kubo J; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):271-6. PubMed ID: 20097298
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.
Dixon R; Job S; Oliver R; Tompson D; Wright JG; Maltby K; Lorch U; Taubel J
Br J Clin Pharmacol; 2008 Sep; 66(3):396-404. PubMed ID: 18662287
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers.
Xu FY; Huang JH; He YC; Liang LY; Li LJ; Yang J; Yin F; Xu L; Zheng QS; Wang K
Acta Pharmacol Sin; 2017 Nov; 38(11):1580-1588. PubMed ID: 28713157
[TBL] [Abstract][Full Text] [Related]
20. Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects.
Kambayashi R; Goto A; Izumi-Nakaseko H; Oikawa I; Ikeda N; Matsuda K; Takei Y; Matsumoto A; Kumagai Y; Sugiyama A
J Pharmacol Sci; 2022 Nov; 150(3):191-199. PubMed ID: 36184124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
